RVNC INVESTOR ALERT: Kirby McInerney LLP Reminds Revance Therapeutics, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
Portfolio Pulse from
Kirby McInerney LLP alerts investors of Revance Therapeutics, Inc. about the March 4, 2025 deadline to become lead plaintiff in a class action lawsuit. The lawsuit concerns those who acquired Revance securities between February 29, 2024, and December 6, 2024.
February 20, 2025 | 11:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Revance Therapeutics faces a class action lawsuit with a lead plaintiff deadline on March 4, 2025. This legal issue could impact investor sentiment and stock price.
The class action lawsuit against Revance Therapeutics is a significant legal issue that could negatively impact investor sentiment and the stock price. The approaching deadline for lead plaintiff status highlights the seriousness of the case.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100